Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (019175) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (019175:KRX), powered by AI.

Current Price
₩14,110
P/E Ratio
82.0
Market Cap
28.1B
Sector
Healthcare
What is the Shin Poong Pharmaceutical Co., Ltd. Preferred Stock stock price forecast?

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock is currently trading at ₩14,110. View real-time AI analysis on Alpha Lenz.

What is Shin Poong Pharmaceutical Co., Ltd. Preferred Stock insider trading activity?

View the latest insider trading data for Shin Poong Pharmaceutical Co., Ltd. Preferred Stock on Alpha Lenz.

What is Shin Poong Pharmaceutical Co., Ltd. Preferred Stock's P/E ratio?

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock's P/E ratio is 82.0.

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock

KRX · 019175
₩14,110+110(+0.79%)Market closedKRX regular session 09:00–15:30 KST
Ask about Shin Poong Pharmaceutical Co., Ltd. Preferred Stock's future dividend policy...
Alpha Chat Insight

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock trades at a P/E of 82.0 (premium valuation) with modest ROE of 3.4%.

Ask for details

Company Overview

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock is a type of equity security that represents a financial claim on the company distinct from its common stock. These shares are designed to provide shareholders with preferential treatment in dividend distributions and, potentially, in bankruptcy proceedings, depending on the company's policies. Shin Poong Pharmaceutical, a key player in the pharmaceutical industry, focuses on developing, manufacturing, and distributing a wide range of medical products, including medications, vaccines, and active pharmaceutical ingredients. This preferred stock offers a stable dividend income, which can be particularly appealing to investors seeking consistent returns without necessarily benefiting from voting rights associated with common stock. Predominantly impacting healthcare and pharmaceutical sectors, Shin Poong's market role is crucial, given its commitment to innovative drug development and expanding global healthcare access. The preferred stock serves as a crucial financial instrument, facilitating the company’s capital-raising efforts while ensuring shareholders receive a return on investment during profitable periods.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees809

Company Statistics

FY 2025

Profile

₩28,096,255,300Market Cap
₩234,680,653,220Revenue
1.99MShares Out
809Employees

Margins

43.75%Gross
10.83%EBITDA
6.07%Operating
3.60%Pre-Tax
3.57%Net

Valuation

82.03P/E
2.68P/B
3.08EV/Sales
28.85EV/EBITDA
54.58P/FCF

Growth (CAGR)

3.89%Rev 3Yr
3.48%Rev 5Yr
N/AOp Inc 3Yr
12.69%Op Inc 5Yr
N/ANet Inc 3Yr
10.70%Net Inc 5Yr

Returns

2.42%ROA
3.35%ROE
3.21%ROIC

Financial Health

₩47,432,744,880Cash & Cash Equivalents
₩34,305,940,270Net Debt
30.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (ticker: 019175) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 809 employees. Market cap is $28.1B.

The current price is ₩14,110 with a P/E ratio of 82.03x and P/B of 2.68x.

ROE is 3.35% and operating margin is 6.07%. Annual revenue is $234.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Shin Poong Pharmaceutical Co., Ltd. Preferred Stock (019175) Stock Forecast 2026 ₩14,110 — Price, Financials & Analyst Targets | Alpha Lenz